Fig. 3From: Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE studyOS in previously treated a and treatment-naive b patients in ipilimumab-treated and non-ipilimumab–treated cohorts. IPI ipilimumab, OS overall survivalBack to article page